This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Malcolm M. DeCamp, MD; Robert H. Demling, MD

JAMA. 1988;260(4):530-534.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE SYNDROME of multisystem organ failure (MSOF) currently affects a wide variety of critically ill or injured patients. The mortality rate is well in excess of 60%. Its natural course requires long stays in the intensive care unit and consumes excessive monetary, physician, and hospital resources. The emergence of MSOF is directly related to improvements in organ system support and monitoring, which have made it possible to sustain previously lethal critical illness. The syndrome is characterized by a hyperdynamic, hypermetabolic state identical to that seen in sepsis. The term sepsis syndrome also is used to reflect the fact that infection, although frequently present, is not essential for initiating or perpetuating progressive organ failure. A systemic inflammatory response modulated by a cascade of soluble protein and lipid mediators seems to be the final common pathway linking the sepsis syndrome with MSOF. Herein, we review the origin and presentation of MSOF and . . . [Full Text PDF of this Article]

Author Affiliations
From the Longwood Area Trauma Center and the Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston.

Footnotes
Reprint requests to Longwood Area Trauma Center, 75 Francis St, Boston, MA 02115 (Dr Demling).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?